NICE clinical guidelines [2] (multiple letters)

British Medical Journal

Volumn 329, Issue 7465, 2004, Pages 571-572

  Littlejohns, Peter ^a   Leng, Gillian ^a   Culyer, Tony ^b   Drummond, Mike ^c   Pilling, Stephen ^d   Dutchak, Jacqueline ^e   McInnes, Elizabeth ^f   Macbeth, Fergus ^g   Pearson, Mike ^h   Thomas, Jane ^h   Turnbull, Nancy ⁱ   Eccles, Martin ^j   Wailoo, Allan ^k   Roberts, Jennifer ^k   Brazier, John ^k   McCabe, Chris ^k  

^a Natl Inst for Clinical Excellence   (United Kingdom)

^b INSTITUTE FOR WORK AND HEALTH   (Canada)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Natl Collaborating Ctr Acute Care   (United Kingdom)

^f Natl Collaborating Ctr Nursing S   (United Kingdom)

^g Natl Collaborating Ctr for Cancer   (United Kingdom)

^h Natl Collaborating Ctr Women C   (United Kingdom)

ⁱ Natl Collaborating Ctr Prim Care   (United Kingdom)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BETA INTERFERON;

CONSUMER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; INFORMATION DISSEMINATION; LETTER; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; SAFETY; SCHIZOPHRENIA; SOCIOECONOMICS; NATIONAL HEALTH SERVICE; NOTE; STANDARD; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; STATE MEDICINE;

EID: 4544286342     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)